Prior research demonstrated that the overexpression of mini-Agrin effectively mitigates dystrophic phenotypes in a laminin-α2-deficient mouse model of congenital muscular dystrophy (CMD). The gene discussed is AGRN; the disease is congenital muscular dystrophy due to LMNA mutation.